Amylin under examination. Fibrillogenic polypeptide hormone of the pancreas
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2014, Vol 68, Issue
Abstract
In patients or animals affected by type 2 diabetes mellitus (DM2, non-insulin dependent diabetes mellitus [NIDDM]) some pathological deposits, called amyloid, are observed among cells of islets of Langerhans. Among other constituents, deposits consist of an insoluble, fibrillar form of peptide neurohormone called amylin, produced by pancreatic beta cells. It is thought that formation of fibrillar deposits of misfolded and aggregated peptide is highly toxic to beta cells and leads to cell dysfunction, cell loss, pancreas destruction and progress of the disease. This relatively small 37-amino acid peptide constitutes a serious scientific, research and to some extent a medical problem. This article presents amylin as a hormone, neurohormone and as a fibrillating molecule which participates in amyloid deposit formation in human and animal pancreas. The role of some amino acids important for fibril formation has been highlighted.
Authors and Affiliations
Małgorzata Marszałek
Znaczenie polimorfizmu HLA-E w odpowiedzi immunologicznej
HLA-E jest najlepiej poznanym antygenem MHC klasy Ib i najmniejszą polimorficzną cząsteczką ze wszystkich molekuł MHC klasy I. W ludzkiej populacji opisano zaledwie dziesięć alleli, które kodują trzy różne białka. Tylko...
The renin-angiotensin-aldosterone system (RAAS) – physiology and molecular mechanisms of functioning
Secretion of renin juxtaglomerular cells into bloodstream initiates activation of an enzymatic-hormonal cascade known as the RAAS (renin – angiotensin – aldosterone system). As a result, blood pressure is increased by th...
Mechanizmy utrzymania sterylności układu moczowego
W warunkach prawidłowego funkcjonowania organizmu układ moczowy jest jałowy, wyjątek stanowi ujście cewki moczowej. Poprzez cewkę moczową drobnoustroje mogą wnikać do układu moczowego, kolonizując dalsze partie układu mo...
PARP1 inhibitors: contemporary attempts at their use in anticancer therapy and future perspective
Current cancer therapies are based mainly on the use of compounds that cause DNA damage. Unfortunately, even the combination therapies do not give rewarding effects, due to the high efficiency of DNA damage repair mechan...
Activity of guanylyl cyclase activators on the reaction of tracheal smooth muscle contraction
Introduction: The subject of the study compare the influences of YC-1 guanylyl cyclase activator with ODQ guanylyl cyclase inhibitor on the tracheal smooth muscle contraction induced by carbachol. The study specified the...